Vinorelbine in Treating Children With Recurrent or Refractory Cancers

Completed · Phase 2

Conditions studied: Brain and Central Nervous System Tumors, Neuroblastoma, Sarcoma

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of vinorelbine in treating children with recurrent or refractory cancer.

Key facts

Study ID
NCT00003234
Run by
Children's Oncology Group
People needed
50
Starts
1998-05-01
Expected to finish
2007-03-01
Last updated by the study team
2014-07-28

Who can join

Age: any, up to 21. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.